Study to evaluate COVID-19 vaccines' strength

June 9, 2022

Study to evaluate COVID-19 vaccines' strength

A new study involving researchers from UW Medicine, Seattle Children's and the Kaiser Permanente Center for Health Research in Portland, Oregon, aims to shed light on the spread of COVID-19 in the region and how well vaccines protect against the virus over time.

“We hope that we can answer some important questions: particularly in the younger kids, about how well does the vaccine protect? How long does the protection last? What does it look like when you get a breakthrough infection when you've been vaccinated, and boosted, and boosted again,” said Dr. Helen Y. Chu, an associate professor of medicine at the University of Washington School of Medicine and a co-leader of the CASCADIA study.

Researchers seek to recruit 3,500 children and adults in the Pacific Northwest to take part in the study. Participants can range in age from 6 months to 49 years.

Learn more about the details of the study and how to be screened for eligibility in our news release.

Download broadcast-ready soundbites featuring Dr. Helen Y. Chu describing the CASCADIA study.

The CASCADIA study

Terms of appropriate usage of file downloads

  • News reporters and news organizations may freely republish and distribute videos, still images and audio files produced by UW Medicine and the University of Washington School of Medicine.
  • Works must be attributed/credited appropriately (for example, “UW Medicine” – as denoted in the file) and must not be used for commercial purposes.
  • These visual and audio files may not be used to exploit or misrepresent UW Medicine or the University of Washington.
  • UW Medicine often licenses still images from Thinkstock but cannot grant republishing rights. You may not republish single image files credited to Thinkstock.
  • Logos of UW Medicine and University of Washington Health Sciences schools may not be republished without explicit permission. Contact us by phone or email: 206.543.3620 or